法国致敏程度与 deceased-donor 肾移植可及性研究
这项回顾性多中心队列研究纳入2011至2021年法国14,485例成人肾移植候选者,用TGI评估致敏并映射为cPRA分层。结果显示cPRA≥96%时DDKT可及性急剧下降,cPRA≥97%时等待列表脱落风险增加,提示现行优先分配策略对超高致敏亚组覆盖不足。
要点
- cPRA≥96%是DDKT可及性受损的阈值,cPRA 100%时调整SHR仅0.082。
- cPRA≥97%起等待列表脱落风险增加,cPRA 100%时sHR达2.713。
- cPRA 85%–95%候选者DDKT可及性保持,符合可接受抗原通路预期。
核心结论
- 在法国基于TGI的分配系统中,cPRA≥96%标志DDKT可及性受损,cPRA≥97%识别出等待列表脱落过多。
- 这些发现定义了当前优先分配策略服务不足的超高致敏亚组,支持在96%至100%范围内优化分配策略。
研究设计与样本
- 回顾性多中心队列研究,纳入2011至2021年列出的14,485例成人肾移植候选者。
- 致敏用TGI(0–100)测量,并以cPRA标记分层报告以便国际可读性。
- 主要结局为DDKT可及性,活体供肾移植、死亡和剔除作为竞争事件;次要结局为等待列表脱落(死亡或剔除)。
- 采用Fine-Gray模型调整关键人口学、临床和免疫学变量,截断至10年。
主要发现
- DDKT可及性随致敏程度增加而逐渐下降,从cPRA≥96%起急剧下降。
- 与cPRA 0%相比,DDKT的调整亚分布风险比(SHR)在96%为0.781,97%为0.658,98%为0.701,99%为0.353,100%为0.082。
- 等待列表脱落风险从cPRA≥97%开始增加(sHR:1.793),在100%时达到2.713。
- cPRA 85%至95%的候选者DDKT可及性保持,与可接受抗原通路的预期效果一致。
临床怎么用
- 临床可关注cPRA≥96%的候选者DDKT可及性下降,cPRA≥97%者等待列表脱落风险增加。
- 对cPRA 96%至100%的超高致敏候选者,可考虑优化分配策略以改善公平性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Highly sensitized kidney transplant candidates have reduced access to deceased-donor kidney transplantation (DDKT) and worse waitlist outcomes. In France, allocation relies on sensitization-based prioritization through the acceptable-antigen pathway driven by the Taux de Greffons Incompatibles (TGI)' however, the sensitization threshold at which this system fails to preserve equity remains unclear. METHODS: We conducted a retrospective multicenter cohort study including 14,485 adult kidney transplant candidates listed between 2011 and 2021. Sensitization was measured using TGI (0-100) and reported using calculated panel reactive antibody (cPRA)-labeled strata for international readability. Access to DDKT was the primary outcome, with living-donor transplantation, death, and delisting treated as competing events. The secondary outcome was waitlist attrition (death or delisting). Fine-Gray models adjusted for key demographic, clinical, and immunologic variables were truncated at 10 years. RESULTS: Access to DDKT declined progressively with increasing sensitization and fell sharply from cPRA ≥ 96%. Compared with cPRA 0%, the adjusted subdistribution hazard ratio (SHR) for DDKT was 0.781 at 96%, 0.658 at 97%, 0.701 at 98%, 0.353 at 99%, and 0.082 at 100%. Conversely, the risk of waitlist attrition increased from cPRA ≥ 97% (sHR: 1.793), reaching 2.713 at 100%. Candidates with cPRA of 85% to 95% retained preserved access, consistent with the intended effect of the acceptable-antigen pathway. CONCLUSION: In the French TGI-based allocation system, cPRA ≥ 96% marks a threshold of impaired access to DDKT, whereas cPRA ≥ 97% identifies excess waitlist attrition. These findings define an ultrasensitized subgroup insufficiently served by current prioritization and support refined allocation strategies within the 96% to 100% range.
引用
- Bertrand D, Gatault P, Poulain C, et al. Sensitization and Deceased-Donor Kidney Transplant Access in France. Kidney Int Rep. 2026. PMID: 41853743. doi:10.1016/j.ekir.2026.106340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。